DRUGPATENTWATCH
DrugPatentWatch is a global biopharmaceutical drug patent and generic entry business intelligence. It serves companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. DrugPatentWatch platform offers branded pharmaceutical global business intelligence and forecasting, generic drug and API manufacturer portfolio management, and healthcare payer formulary management and budget management.
DRUGPATENTWATCH
Industry:
Biotechnology Legal Legal Tech Pharmaceutical
Founded:
2002-01-01
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.drugpatentwatch.com
Total Employee:
1+
Status:
Active
Contact:
202-780-9367
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag ReCAPTCHA JsDelivr Cloudflare JS
Current Employees Featured
Founder
Official Site Inspections
http://www.drugpatentwatch.com Semrush global rank: 1.5 M Semrush visits lastest month: 18 K
- Host name: 104.21.46.112
- IP address: 104.21.46.112
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "DrugPatentWatch"
About DrugPatentWatch
About DrugPatentWatch DrugPatentWatch provides actionable business intelligence on small-molecule drugs DrugPatentWatch is a valuable resource that offers insights into global drug patents, helping stakeholders like …See details»
DrugPatentWatch is a time-saving powerhouse
People switch to DrugPatentWatch because they're tired of the high cost and low quality of their analysts. → See why others have switched. Skip the Delay. See What the Analysts See — Now. You don't have to wait for analysts. Every …See details»
DrugPatentWatch - Crunchbase Company Profile
DrugPatentWatch is a global biopharmaceutical drug patent and generic entry business intelligence. It serves companies ranging from biopharmaceutical …See details»
DrugPatentWatch Pharmaceutical Drug Patent …
Global biopharmaceutical drug patent and generic entry business intelligence. DrugPatentWatch Supports Critical Business Decisions: >Payers: Formulary and pharmacy & therapeutics (P&T) Anticipate ...See details»
DrugPatentWatch 2025 Company Profile: Valuation, …
DrugPatentWatch is headquartered in Washington, DC. What is the size of DrugPatentWatch? DrugPatentWatch has 4 total employees. What industry is …See details»
DrugPatentWatch - Products, Competitors, Financials, Employees ...
The DrugPatentWatch database was obtained from DrugPatentWatch.com . This work was supported by grants from the Institute for New Economic Thinking and the National Biomedical …See details»
Frequently Asked Questions - DrugPatentWatch
Enterprise Plans are available for unlimited users within your organization. The other plans are for single users, but multiple accounts can be purchased for a substantial discount. ... Friedman, …See details»
DrugPatentWatch, a Global Biopharmaceutical …
DrugPatentWatch is famous worldwide for providing Business intelligence on pharmaceutical and biologic drugs - patents, generics, pricing, sales, litigation services to leading biopharmaceutical ...See details»
DrugPatentWatch - Org Chart, Teams, Culture & Jobs - The Org
View DrugPatentWatch's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
DrugPatentWatch - InnMind Company Profile & Funding
Do you want insights into the biggest revenue-changing events? Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market. We are a global …See details»
DrugPatentWatch - Facebook
DrugPatentWatch. 189 likes. DrugPatentWatch provides actionable business intelligence on small-molecule drugs and the 110,000 global patents covering them. ... As a pharmaceutical …See details»
DrugPatentWatch - Rapid
The DrugPatentWatch platform contains deep analytics on pharmaceutical drugs, the patents protecting them in 130+ countries, clinical trials, patent applications, API vendors, and more. …See details»
DrugPatentWatch - Vectorlens
DrugPatentWatch is geared for pharmaceutical and biotechnology companies, investors and researchers looking to stay on top of market developments and spot opportunities. It's a …See details»
The basics of drug patent searching - DrugPatentWatch – Make …
Feb 18, 2025 WIPO (World Intellectual Property Organization)[4] Each of these databases offers a unique perspective on the global patent landscape, and mastering their use is essential for …See details»
DrugPatentWatch Reviews in 2025 - SourceForge
Learn about DrugPatentWatch. Read DrugPatentWatch reviews from real users, and view pricing and features of the Drug Discovery software. Join/Login; Business Software ... Protect your …See details»
DrugPatentWatch Reviews - 2025 - Slashdot
DrugPatentWatch user reviews from verified software and service customers. Explore ratings, reviews, pricing, features, and integrations offered by the Drug Discovery product, …See details»
DrugPatentWatch – Transform Data into Market Domination
The pharmaceutical industry relies heavily on patent protection to safeguard innovations and maintain market exclusivity. With global prescription drug revenue […]See details»
Truth About Drugpatentwatch.com. Is Drugpatentwatch.com the …
Read reviews of Drugpatentwatch.com. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Make Better Decisions with DrugPatentWatch
DrugPatentWatch aids in identifying and evaluating commercial opportunities, forecasting drug pipelines, and assessing levels of generic competition. It can help you track investigational …See details»
DrugPatentWatch Small Molecules Dashboard
5 days ago DrugPatentWatch ® Estimated Upcoming Generic Entry Dates Anticipated Loss-of-Exclusivity (LOE) dates for branded drugs. Unapproved (DESI) Drugs. Upcoming 180-Day …See details»